---
title: "What ZhongAn Holders Got Wrong Before The Slide"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305557631.md"
description: "ZhongAn Online P&C Insurance shares fell 44.4% in early 2026, contradicting bullish forecasts of 9.3% revenue growth and a 33.5x P/E. While H1 2026 results showed strong net margins at 8.5%, challenging cautious regulatory views, the stock trades at HK$9.18. Analysts argue current valuations may undervalue AI-driven efficiency and ecosystem scale, suggesting potential for recovery if these factors offset pressures in consumer finance."
datetime: "2026-11-15T00:34:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305557631.md)
  - [en](https://longbridge.com/en/news/305557631.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305557631.md)
generator: "portal-rs"
---

# What ZhongAn Holders Got Wrong Before The Slide

If you backed ZhongAn Online P & C Insurance at the start of 2026, the result has been painful. For ZhongAn Online P & C Insurance shareholders, the loss from the start of the year was 44.4%, including dividends. If that decision was based on a bullish December 2025 view that assumed 9.3% revenue growth, a 2.7% profit margin and a future P/E of 33.5x over three years, which of those moving parts did the original case fail to allow for?

The move put ZhongAn Online P & C Insurance in the middle of this trade. Scan 23 cryptocurrency and blockchain stocks for other companies exposed to it.

## The Argument ZhongAn Investors Were Weighing Up

The shares cost HK$16.09 at the start of the period, and ZhongAn Online P & C Insurance sat between two competing stories about where the business could reasonably go next.

On the upbeat side, one December 2025 view pointed to a Fair Value of HK$21.83, a notional price implied by its model of the future. That case leaned on 9.3% revenue growth and a 2.7% profit margin, supported by digital transformation and new product lines.

A more cautious July 2025 Narrative put Fair Value at HK$13.21, again an implied target from its own forecasts. This view focused on rising data privacy rules in China that could restrict ZhongAn’s use of customer data and weigh on product development and efficiency.

## What The Results Changed For ZhongAn Online P & C Insurance

The H1 2026 report gave ZhongAn Online P & C Insurance bulls something concrete. Total revenue reached CNY 18,310.609m and net income excluding extra items was CNY 1,549.964m, with net margin at 8.5%. That profitability level challenged the earlier cautious view that rising costs and regulation would keep returns weak. However, it did not fully validate the earlier rich P/E assumption.

The lesson is simple. When a thesis leans on margin expansion, track net income and net margin in each filing rather than just top line or share price moves.

## What Today's ZhongAn Price Already Assumes

Today ZhongAn Online P & C Insurance trades at HK$9.18, with this analyst consensus Narrative on Simply Wall St arguing that its Fair Value sits above the current level.

The Narrative leans on AI driven efficiency and ecosystem scale across health, pet and ZA Bank. A buyer now would need to believe these engines can offset pressure in consumer finance and slower auto cover.

> *"The current valuation implies the market is not fully pricing in this narrative that ZhongAn Online P & C Insurance is undervalued and that sustained underwriting profit, growing AI deployment and a second profit engine at ZA Bank could matter more than the contraction in consumer finance."*

That disagreement has a full argument behind it. **→ Uncover the higher Fair Value this Narrative argues for**

## Find Your Own Contrarian Opportunity

This company's disappointment is already part of the story. Your next idea could come from looking where the price and the possibilities still seem far apart. Here are three companies priced below our estimates.

-   Company 1 - 29% below our estimate - uses quick payback boutique openings and expanding digital channels to pull more shoppers into its ecosystem.
-   Company 2 - 33% below our estimate - builds AI-ready cloud infrastructure and database services that large customers pre-commit to through multiyear contracts.
-   Company 3 - 28% below our estimate - shifts its probiotic mix toward adult and oral health products sold through more direct channels.

Those are three of them. See **every one of the 199 undervalued companies on it →**

### Related Stocks

- [01860.HK](https://longbridge.com/en/quote/01860.HK.md)

## Related News & Research

- [Mobvista Holds Extraordinary General Meeting](https://longbridge.com/en/news/306090495.md)
- [Mobvista Announces Extraordinary General Meeting](https://longbridge.com/en/news/303771989.md)
- [South Korea prepares market stabilisation funds after KOSPI hits 10-month low](https://longbridge.com/en/news/306391779.md)
- [Lenovo Group (LNVGF): New Buy Recommendation for This Technology Giant](https://longbridge.com/en/news/306391832.md)
- [Hanil Feed's (KOSDAQ:005860) Conservative Accounting Might Explain Soft Earnings](https://longbridge.com/en/news/306378716.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**